Osteosarcoma is a primary bone cancer that arises in developing bones in young adults who are experiencing growing spurts. Chemotherapy is the most common successful treatment used currently, but there are many limitations and side effects caused by these DNA damaging chemotherapies to osteosarcoma patients. The five-year survival rate for osteosarcoma is very poor in that 40% of the patients die due to their osteosarcomas and the remaining 60% who are cured of their osteosarcoma succumb to heart failure or secondary cancers. Chemotherapy regimens used to treat osteosarcoma patients result in anti-tumour activity by exerting DNA damage. This study investigated the efficacy and safety of a chosen panel of chemotherapy drugs on murine osteosarcoma (OS) cell lines.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Osteosarcoma is a primary bone cancer that arises in developing bones in young adults who are experiencing growing spurts. Chemotherapy is the most common successful treatment used currently, but there are many limitations and side effects caused by these DNA damaging chemotherapies to osteosarcoma patients. The five-year survival rate for osteosarcoma is very poor in that 40% of the patients die due to their osteosarcomas and the remaining 60% who are cured of their osteosarcoma succumb to heart failure or secondary cancers. Chemotherapy regimens used to treat osteosarcoma patients result in anti-tumour activity by exerting DNA damage. This study investigated the efficacy and safety of a chosen panel of chemotherapy drugs on murine osteosarcoma (OS) cell lines. 72 pp. Englisch. N° de réf. du vendeur 9786139947591
Quantité disponible : 2 disponible(s)
Vendeur : moluna, Greven, Allemagne
Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Jeevananda ThanuriThanuri Jeevananda is a Microbiologist, a researcher who has received B.Sc. in Microbiology and M.Sc. in Biotechnology. Her educational background in science and technology has always mesmerised her to investigate t. N° de réf. du vendeur 311210064
Quantité disponible : Plus de 20 disponibles
Vendeur : Revaluation Books, Exeter, Royaume-Uni
Paperback. Etat : Brand New. 72 pages. 8.66x5.91x0.17 inches. In Stock. N° de réf. du vendeur zk6139947596
Quantité disponible : 1 disponible(s)
Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne
Taschenbuch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -Osteosarcoma is a primary bone cancer that arises in developing bones in young adults who are experiencing growing spurts. Chemotherapy is the most common successful treatment used currently, but there are many limitations and side effects caused by these DNA damaging chemotherapies to osteosarcoma patients. The five-year survival rate for osteosarcoma is very poor in that 40% of the patients die due to their osteosarcomas and the remaining 60% who are cured of their osteosarcoma succumb to heart failure or secondary cancers. Chemotherapy regimens used to treat osteosarcoma patients result in anti-tumour activity by exerting DNA damage. This study investigated the efficacy and safety of a chosen panel of chemotherapy drugs on murine osteosarcoma (OS) cell lines.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 72 pp. Englisch. N° de réf. du vendeur 9786139947591
Quantité disponible : 1 disponible(s)
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Taschenbuch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Osteosarcoma is a primary bone cancer that arises in developing bones in young adults who are experiencing growing spurts. Chemotherapy is the most common successful treatment used currently, but there are many limitations and side effects caused by these DNA damaging chemotherapies to osteosarcoma patients. The five-year survival rate for osteosarcoma is very poor in that 40% of the patients die due to their osteosarcomas and the remaining 60% who are cured of their osteosarcoma succumb to heart failure or secondary cancers. Chemotherapy regimens used to treat osteosarcoma patients result in anti-tumour activity by exerting DNA damage. This study investigated the efficacy and safety of a chosen panel of chemotherapy drugs on murine osteosarcoma (OS) cell lines. N° de réf. du vendeur 9786139947591
Quantité disponible : 1 disponible(s)
Vendeur : preigu, Osnabrück, Allemagne
Taschenbuch. Etat : Neu. Osteosarcoma | Investigation of potential new treatments for the bone cancer Osterosarcoma | Thanuri Jeevananda | Taschenbuch | 72 S. | Englisch | 2019 | LAP LAMBERT Academic Publishing | EAN 9786139947591 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu. N° de réf. du vendeur 117309214
Quantité disponible : 5 disponible(s)